Botulinumtoxin Type A
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Botulinumtoxin Type A, covering 2017-10-27 to 2017-10-27. Get the full timeline:
Most recent: Clinical Trial Update: Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy [Phase 3]